**REGISTERED CHARITY NUMBER: 1174480** **REPORT OF THE TRUSTEES AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2021** **FOR** **ORCHARD** Staffords Chartered Accountants Unit 1, Cambridge House Camboro Business Park Oakington Road, Girton CAMBRIDGE Cambridgeshire CB3 0QH **ORCHARD** **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2021** **----- Start of picture text -----**
Page
Report of the Trustees 1 to 4
Independent Examiner's Report 5
Statement of Financial Activities 6
Balance Sheet 7
Notes to the Financial Statements 8 to 15
**----- End of picture text -----**
**ORCHARD** ## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 28 FEBRUARY 2021** The trustees present their report with the financial statements of the charity for the year ended 28 February 2021. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). ## **OBJECTIVES AND ACTIVITIES** ## **Objectives and aims** Orchard is a charity focusing on developing treatments for patients suffering from obsessive-compulsive disorder (OCD), a serious mental illness. We work with academia, clinicians, pharmaceutical/biotech companies, government agencies, patients and other charities to fast-track the development of new and innovative treatments for OCD. OCD is a common, chronic and severely disabling mental illness that affects at least a million people in the UK alone. It is characterised by intrusive thoughts (obsessions) and accompanying rituals (compulsions) aimed at reducing anxiety and distress. Sixty per cent of OCD patients are also depressed and many are suicidal. The lifetime prevalence of OCD is 2-3 %. It affects all population groups regardless of gender and culture. There is an urgent need for the development of new and better treatments, yet the field is severely underfunded. Very little research is carried out by the pharmaceutical industry, and funding for academic research is scarce and difficult to obtain. This is why we have set up Orchard in order to raise much-needed funding for OCD research. ## **Public benefit** In setting our objectives and planning our activities, the Trustees have given careful consideration to the Charity Commission's general guidance on public benefit. For the public benefit, the charitable objects are: 1. to promote and protect the physical and mental health of sufferers of OCD and related disorders, their families and carers including (but not limited to) through the provision of support, education and practical advice. 2. to improve the diagnosis, treatment and care of persons suffering from OCD and related disorders and their families and carers by facilitating, setting up and supporting (including (but not limited to) by way of funding) specialised and highly skilled, multi-disciplinary international teams to develop new and effective methods of diagnosis, treatment and management of and services for OCD and related disorders and to assist in the publication and dissemination of the useful results. 3. to assist in such ways as the charity Trustees think fit any charity whose aims include promoting and/or protecting the physical and mental health of sufferers of OCD and related disorders, their families and carers through the provision of funding, grants, support and practical advice. 4. to advance the education of the general public in all areas relating to OCD and related disorders and to raise awareness of and reduce the stigma related to OCD and related disorders and assist in such ways as the charity Trustees think fit including (but not limited to) through lectures, seminars, webinars, workshops, through the internet and social media and publication of newsletters and research papers and in any other ways in which the charity Trustees think fit. 5. to advance the education of the public in general (and particularly amongst healthcare professionals and scientists) on the subject of OCD and related disorders and to promote research for the public benefit in all aspects of that subject and to assist in the publication and dissemination of the useful results. The Trustees have complied with the duty in Section 4 of the 2011 Charities Act to have due regard to guidance published by the Charity Commission, including public benefit guidance. Page 1 **ORCHARD** ## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **ACHIEVEMENT AND PERFORMANCE** ## **Key achievements, principal activities and fundraising** 2020 was a big year for Orchard, following on from our first call for proposals at the end of 2019 to identify a hard-to-fund research project that could make a significant difference to the lives of OCD patients. The call was global and was sent out to OCD researchers around the world, such as through networks like the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). The Orchard Scientific Advisory Board - made up of lead OCD scientists and clinicians from around the world - then evaluated the proposals according to their scientific validity, clinical relevance, track record and crowdfundability. The three best projects were put to a public vote on social media, thanks to a partnership with intrusivethoughts.org, so that OCD patients, their relatives and members of the public could choose which one would win. The top project was a clinical study of psilocybin - a psychedelic - at Imperial College under the leadership of Prof David Nutt, a world renowned neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there. Prof Nutt will carry out a clinical study on 15 patients with OCD and 15 controls (without OCD). These will be recruited through Prof Naomi Fineberg's OCD specialist centre. Prof Fineberg is a Consultant Psychiatrist and Visiting Professor at the University of Hertfordshire and a trustee of Orchard. Participants in the study will be given a low dose of psilocybin within a therapeutic unit at Imperial College. The clinical team will then evaluate the OCD patients' levels of obsessions and compulsions to see if the medicine has helped reduce these. We expect this study to start in the summer of 2021. The aim of the project is to show the feasibility of carrying out a much larger study with psilocybin on more patients in order to then seek regulatory approval for the drug to be used as a treatment for OCD. From January to May 2020, we worked on preparing the crowdfunding campaign to fund this study. We put together a group of volunteers and shared out the tasks. These volunteers included three OCD patients, two mothers of OCD patients, and three friends/siblings of OCD patients. We met via video conferencing twice a week to organize the campaign. We worked with a video company called Dragon Light Films to make a three-minute video for the campaign. The video included an interview with Prof David Nutt and with Reuben Fletcher, a teenager who has suffered from severe OCD. They focused on how existing treatments are not effective for many OCD patients and why psilocybin could be a game-changer if the study is positive. We chose the crowdfunding platform Chuffed.org to carry out the campaign. This is a platform that focuses exclusively on charity crowdfunding. Following recommendations from our crowdfunding advisor Jes Bailey, we chose Chuffed.org because they have a user friendly system and could offer personal advice on how to improve and boost the campaign. We then ran the crowdfunding campaign in May 2021 in order to raise £60,000 to help fund the project. This also raised awareness about OCD through social and traditional media and helped reduce some of the stigma surrounding the condition. We hit the target of £60,000 and received matched funding of £60,000 from a foundation, for a total of £120,000 for this research project. Page 2 **ORCHARD** ## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 28 FEBRUARY 2021** We also carried out social media live events to raise awareness about OCD, hosted by TV journalist and Orchard trustee Sean Fletcher, whose son Reuben featured in our video. The first social media live was with the best-selling author David Adam, who wrote a book about his OCD called 'The Man Who Couldn't Stop: the Truth about OCD'. The second social media live was with author and Daily Telegraph journalist Bryony Gordon, who has suffered from severe OCD. The third and final social media live was with Prof David Nutt, who explained how the study of psilocybin will run. We also received funding for a second OCD research project in September 2020: a study designed to test whether small electrical currents applied to the scalp (called transcranial direct current stimulation, or tDCS) can help treat OCD. Some current passes into the brain where it may change brain functioning. Evidence suggests this could help ease OCD symptoms. This type of brain stimulation is new and experimental, so this project aims to answer basic questions, including if this stimulation shows signs of working, what are the side effects and if doctors and patients are willing to use it. The project also looks at which areas of the brain should be targeted and how long the effects last. Once this study has been completed, we will have collected valuable information about whether this form of stimulation is a useful treatment for people with OCD, and about how this stimulation might be best used on a wide scale in practice. The information collected will be used to design a larger scale study for which we will seek funding from appropriate NHS programmes. ## **FINANCIAL REVIEW** ## **Financial position** The charity is funded principally from donations. During the period donations of £97,882 (2020: £20,981) were received. This included donated services of £23,247 (2020: £nil). Grants are sought for research into particular areas. During this financial year grants totalling £63,504 (2020: £30,000) were received. Expenditure during the period was £45,514 (2020: £7,632); leaving reserves of £176,333 (2020: £60,459) of which £134,546 (2020: £32,000) were restricted and £nil (2020: £489) represented the net book value of fixed assets. ## **Reserves policy** The Trustees aim to maintain general reserves to cover 8 months of expenditure, net of depreciation. At the year end the general reserve was £41,787 (2020: £27,970). ## **FUTURE PLANS** We have ambitious plans for the future, including a potential partnership with a new OCD foundation in the USA and the development of a strategic plan to accelerate research into the causes of OCD and potential new treatments. We are also starting to work on an international patient registry in order to encourage OCD patients to register and indicate whether they would be interested in participating in research. We hope to organise a scientific conference - possibly virtual - into the latest research into OCD in order to boost collaboration and cross-sector work. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity constitutes a Charitable Incorporated Organisation and is governed by its governing document, registered on 1 September 2017 and amended on 7 September 2018. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Registered Charity number** 1174480 Page 3 **ORCHARD** ## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **Principal address** 66 Devonshire Road Cambridge CB1 2BL ## **Trustees** ## **Appointment, resignation and reappointment of the trustees** The trustees of Orchard during the financial year ended 28 February 2021 were as follows: |**Name**|**Date appointed**|**Date on which Trusteeship ended**|**Date reappointed**| |---|---|---|---| |Nicolas Sireau|1 September 2017|1 September 2020|13 April 2021| |Vincenzo Garzya|1 September 2017|1 September 2020|13 April 2021| |Gayaneh Szenkovitis|1 September 2017|1 September 2020|N/A| |Naomi Fineberg|1 September 2017|1 September 2020|13 April 2021| |Sean Fletcher|17 May 2019|N/A|N/A| |Neil Balmer|24 November 2020|N/A|13 April 2021| ||(see notes below)||| Under Orchard's constitution, trustees are appointed for three years. It is unclear whether Neil Balmer's appointment as a trustee on 24 November 2020 was valid, and accordingly he was reappointed as a trustee on 13 April 2021. Between 1 September 2020 and 13 April 2021, there were fewer than three trustees. Under clause 9(3) of Orchard's constitution, if the number of trustees falls below this minimum, the remaining trustee or trustees may act only to call a meeting of the charity trustees, or appoint a new charity trustee. Accordingly, the resolutions of the trustees passed and all actions undertaken by Orchard since 1 September 2020 were ratified at a trustee meeting held on 13 April 2021. The legal fees associated with reinstating the Trustees was offered pro-bono and has been treated as a donation within the accounts. ## **Independent Examiner** Staffords Chartered Accountants Unit 1, Cambridge House Camboro Business Park Oakington Road, Girton CAMBRIDGE Cambridgeshire CB3 0QH Approved by order of the board of trustees on ............................................. and signed on its behalf by: .................................................................... Dr N T Sireau PhD - Trustee Page 4 ## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF ORCHARD** ## **Independent examiner's report to the trustees of Orchard** I report to the charity trustees on my examination of the accounts of Orchard (the Trust) for the year ended 28 February 2021. ## **Responsibilities and basis of report** As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act'). I report in respect of my examination of the Trust's accounts carried out under section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. ## **Independent examiner's statement** I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Matthew Pettifer FCA ICAEW Staffords Chartered Accountants Unit 1, Cambridge House Camboro Business Park Oakington Road, Girton CAMBRIDGE Cambridgeshire CB3 0QH Date: ............................................. Page 5 **ORCHARD** ## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 28 FEBRUARY 2021** |Unrestricted
funds
Notes
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
2
**39,620**
**Charitable activities**
4
Charitable activities
**-**
Investment income
3
**2**
**Total**
**39,622**
**EXPENDITURE ON**
Raising funds
**686**
**Charitable activities**
Charitable activities
**25,608**
**Total**
**26,294**
**NET INCOME**
**13,328**
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
**28,459**
**TOTAL FUNDS CARRIED FORWARD**
**41,787**|Restricted
funds
£
**58,262**
**63,504**
**-**
**121,766**
**2,030**
**17,190**
**19,220**
**102,546**
**32,000**
**134,546**|**2021**
**Total**
**funds**
**£**
**97,882**
**63,504**
**2**
**161,388**
**2,716**
**42,798**
**45,514**
**115,874**
**60,459**
**176,333**|2020
Total
funds
£
20,981
30,000
10| |---|---|---|---| ||||50,991
281
7,351| ||||7,632| ||||43,359
17,100| ||||60,459| The notes form part of these financial statements Page 6 **ORCHARD** ## **BALANCE SHEET 28 FEBRUARY 2021** |Unrestricted
funds
Notes
£
**FIXED ASSETS**
Tangible assets
10
**-**
**CURRENT ASSETS**
Debtors
11
**272**
Cash at bank
**43,855**
**44,127**
**CREDITORS**
Amounts falling due within one year
12
**(2,340)**
**NET CURRENT ASSETS**
**41,787**
**TOTAL ASSETS LESS CURRENT**
**LIABILITIES**
**41,787**
**NET ASSETS**
**41,787**
**FUNDS**
13
Unrestricted funds
Restricted funds
**TOTAL FUNDS**|Restricted
funds
£
**-**
**-**
**134,546**
**134,546**
**-**
**134,546**
**134,546**
**134,546**|**2021**
**Total**
**funds**
**£**
**-**
**272**
**178,401 **
**178,673**
**(2,340)**
**176,333**
**176,333**
**176,333**
**41,787**
**134,546**
**176,333**|2020
Total
funds
£
489
631
61,514
62,145
(2,175)
59,970
60,459
60,459
28,459
32,000
60,459| |---|---|---|---| The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: ............................................. Dr N T Sireau PhD - Trustee The notes form part of these financial statements Page 7 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. ## **Tangible fixed assets** Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. Computer equipment - 33% on cost ## **Taxation** The charity is exempt from tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **Donated services** The value of donated services and gifts in kind provided to the Charity are recognised at their open market value in the period in which they are receivable as incoming resources, where the benefit to the charity can be reliably measured. ## **Debtors** Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. continued... Page 8 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **1. ACCOUNTING POLICIES - continued** ## **Cash at bank and in hand** Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months of less from the date of acquisition or opening of the deposit or similar account. ## **Creditors and provisions** Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be estimated or measured reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due. ## **Financial instruments** The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value. ## **2. DONATIONS AND LEGACIES** |Donations
Donated services and facilities
**3.**
**INVESTMENT INCOME**
Deposit account interest|**2021**
**£**
**74,635**
**23,247**
**97,882 **
**2021**
**£**
**2**|2020
£
20,981
-
20,981
2020
£
10| |---|---|---| continued... Page 9 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **4. INCOME FROM CHARITABLE ACTIVITIES** |Activity
Grants
Charitable activities
Grants received, included in the above, are as follows:
L'Arbre Vert grant
WinTrust (Saracens) Foundation
**5.**
**GRANTS PAYABLE**
Charitable activities
The total grants paid to institutions during the year was as follows:
Hertfordshire Partnership: FEATSOC study|**2021**
**£**
**63,504 **
**2021**
**£**
**30,000**
**33,504 **
**63,504 **
**2021**
**£**
**15,000**
**2021**
**£**
**15,000**|2020
£
30,000| |---|---|---| |||2020
£
30,000
-| |||30,000| |||2020
£
-| |||2020
£
-| ## **6. TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 28 February 2021 nor for the year ended 28 February 2020. ## **Trustees' expenses** During the year no Trustee expenses were paid (2020: nil). ## **7. STAFF COSTS** There were no employees or staff costs during either the current or last period. continued... Page 10 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** |**8.**|**COMPARATIVES FOR THE STATEMENT OF FINANCIAL**|**ACTIVITIES**|||| |---|---|---|---|---|---| |||Unrestricted|Restricted||Total| |||funds|funds||funds| |||£|£||£| ||**INCOME AND ENDOWMENTS FROM**||||| ||Donations and legacies|20,981||-|20,981| ||**Charitable activities**||||| ||Charitable activities|-|30,000||30,000| ||Investment income|10||-|10| ||**Total**|20,991|30,000||50,991| ||**EXPENDITURE ON**||||| ||Raising funds|281||-|281| ||**Charitable activities**||||| ||Charitable activities|7,351||-|7,351| ||**Total**|7,632||-|7,632| ||**NET INCOME**|13,359|30,000||43,359| ||**RECONCILIATION OF FUNDS**||||| ||**Total funds brought forward**|15,100|2,000||17,100| ||**TOTAL FUNDS CARRIED FORWARD**|28,459|32,000||60,459| |**9.**|**NET INCOME/(EXPENDITURE)**||||| ||Net income/(expenditure) is stated after charging/(crediting):||||| ||||**2021**||2020| ||||**£**||£| ||Depreciation - owned assets||**489**||489| ||Independent Examiner's fee||**948**||924| continued... Page 11 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** |**10.**
**TANGIBLE FIXED ASSETS**
**COST**
At 29 February 2020 and 28 February 2021
**DEPRECIATION**
At 29 February 2020
Charge for year
At 28 February 2021
**NET BOOK VALUE**
At 28 February 2021
At 28 February 2020
**11.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Trade debtors
Prepayments and accrued income
**12.**
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Trade creditors
Other creditors|Computer
equipment
£
**1,466**
**977**
**489**
**1,466**
**-**
489
**2021**
2020
**£**
£
**50**
-
**222**
631
**272 **
631
**2021**
2020
**£**
£
**100**
-
**2,240**
2,175
**2,340**
2,175| |---|---| continued... Page 12 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **13. MOVEMENT IN FUNDS** |**Unrestricted funds**
General fund
Designated Fixed Assets
**Restricted funds**
Research into the efficacy of Psilocybin
Research into TDCS
**TOTAL FUNDS**
Net movement in funds, included in the above are as follows:
**Unrestricted funds**
General fund
Designated Fixed Assets
**Restricted funds**
Research into the efficacy of Psilocybin
Research into TDCS
**TOTAL FUNDS**|At
29/2/20
£
**27,970**
**489**
**28,459**
**32,000**
**-**
**32,000**
**60,459**
Incoming
resources
£
**39,622**
**-**
**39,622**
**88,262**
**33,504 **
**121,766**
**161,388**|Net
movement
At
in funds
28/2/21
£
£
**13,817**
**41,787**
**(489)**
**-**
**13,328**
**41,787**
**84,042**
**116,042**
**18,504 **
**18,504 **
**102,546**
**134,546**
**115,874 **
**176,333**
Resources
Movement
expended
in funds
£
£
**(25,805)**
**13,817**
**(489)**
**(489)**
**(26,294)**
**13,328**
**(4,220)**
**84,042**
**(15,000)**
**18,504 **
**(19,220)**
**102,546**
**(45,514)**
**115,874 **| |---|---|---| continued... Page 13 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **13. MOVEMENT IN FUNDS - continued** ## **Comparatives for movement in funds** |||Net|| |---|---|---|---| |||movement|At| ||At 1/3/19|in funds|28/2/20| ||£|£|£| |**Unrestricted funds**|||| |General fund|14,122|13,848|27,970| |Designated Fixed Assets|978|(489)|489| ||15,100|13,359|28,459| |**Restricted funds**|||| |Research into the efficacy of Psilocybin|2,000|30,000|32,000| |**TOTAL FUNDS**|17,100|43,359|60,459| Comparative net movement in funds, included in the above are as follows: ||Incoming|Resources|Movement| |---|---|---|---| ||resources|expended|in funds| ||£|£|£| |**Unrestricted funds**|||| |General fund|20,991|(7,143)|13,848| |Designated Fixed Assets|-|(489)|(489)| ||20,991|(7,632)|13,359| |**Restricted funds**|||| |Research into the efficacy of Psilocybin|30,000|-|30,000| |**TOTAL FUNDS**|50,991|(7,632)|43,359| ## Restricted funds Research into the efficacy of Psilocybin: a grant from L'Arbre Vert Fund towards launching a clinical trial to test the efficacy of psilocybin for the treatment of OCD. Research into TDCS: a grant from the WinTrust Foundation towards the study of Transcranial Direct Current Stimulation. ## Designated funds Designated fixed asset fund: represents the net book value of fixed assets held by the Charity. continued... Page 14 **ORCHARD** ## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 28 FEBRUARY 2021** ## **14. RELATED PARTY DISCLOSURES** There were no related party transactions for the year ended 28 February 2021. Page 15